Subsidies
Subsidies
subsidy
| Title | Code of transcript | Funder | Beneficiary Entity | Call for applications | Date of award | Amount Awarded | Other Funds |
|---|---|---|---|---|---|---|---|
| HE-UHR-RM M7 COLLIMATOR Equipment | IFEQ22/00167 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES Equipment | 22-12-2022 | 79.000,00€ | MRR Funds |
| Validation of epigenetic biomarkers associated with major depression and resistance to antidepressant treatment. | GN2022/57 | GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH | high school of research Sanitaria de Navarra - IdiSNA | 2022 GN Projects of research in health | 22-12-2022 | 79.998,87€ | - |
| Reversal of immunotherapy resistance in lung cancer due to absence of the tumor suppressor gene PTEN | GN2022/50 | GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH | high school of research Sanitaria de Navarra - IdiSNA | 2022 GN Projects of research in health | 22-12-2022 | 76.934,16€ | - |
| Study of the molecular mechanisms involved in the development of adverse remodeling in ischemic cardiomyopathies, for the search of new anti-fibrotic treatments. | GNS2022-20 | GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH | high school of research Sanitaria de Navarra - IdiSNA | 2022 GN Projects of research in health | 22-12-2022 | 79.924,12€ | - |
| Validation of Structures of therapeutic RNA for clinical use. | PDC2022-133961-I00 | MINISTRY OF SCIENCE, INNOVATION AND UNIVERSITIES | Foundation for Applied Medical Research | FIMA 2022 MCI - AEI RESEARCH AND DEVELOPMENT+I PROJECTS FOR PROOF-OF-CONCEPT TESTING | 21-12-2022 | 149.500,00€ | - |
| Probiotics as immunomodulatory agents for vaccines | GN2022/04 | GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH | high school of research Sanitaria de Navarra - IdiSNA | 2022 GN Projects of research in health | 20-12-2022 | 79.119,13€ | - |
| Early treatment strategies of osteomyelitis in the prevention of fracture pseudarthrosis. | GN2022/06 | GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH | high school of research Sanitaria de Navarra - IdiSNA | 2022 GN Projects of research in health | 20-12-2022 | 48.875,00€ | - |
| RodríguezOroz_GN2022/28_Restoration of synaptic function in the premotor state of Parkinson's disease by protein modulation with gene therapy and molecular therapies. | GN2022/28 | GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH | high school of research Sanitaria de Navarra - IdiSNA | 2022 GN Projects of research in health | 16-12-2022 | 79.349,14€ | - |
| Decross-priming dendritic cells as vaccines in an immunotherapy strategy for renal and urothelial cancers. | ICI22/00115 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES research Independent Clinic | 16-12-2022 | 1.007.600,00€ | MRR Funds |
| essay Phase I/II clinical trial for the treatment of graft-versus-host disease with a new generation of mesenchymal stromal cells ectopically expressing CXCR4 and IL10 | ICI22/00067 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES research Independent Clinic | 16-12-2022 | 1.207.250,00€ | - |
| Patient Dignity Question as an intervention for the alleviation of suffering: A mixed-method study in patients with advanced disease. | PI22/01504 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES Projects research | 15-12-2022 | 10.890,00€ | ERDF funds |
| Diagnostic platform of high performing for personalized medicine in patients with acute myeloblastic leukemia. | PMP22/00069 | HIGH SCHOOL CARLOS III HEALTH CENTRE | University of Navarra | 2022 AES Personalized Medicine | 15-12-2022 | 126.252,67€ | - |
| Linking phenotype and molecular genotype to prognosis in Primary Systemic Amyloidosis: A European registry and network of samples to optimize diagnosis and management of Primary Systemic Amyloidosis. | AC22/00057 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES International Joint Programming Projects | 15-12-2022 | 174.845,00€ | MRR Funds |
| Personalising the clinical decision making in ovarian cancer through patient-derived in vitro models. | HIGH SCHOOL CARLOS III HEALTH CENTRE | Foundation for Applied Medical Research | FIMA 2022 AES International partnership Projects | 15-12-2022 | 159.175,50€ | - | |
| Longitudinal analysis of the determinants of intimate partner violence in Spanish adolescents. Follow-up of project Yourlife | PI22/00624 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES Projects research | 15-12-2022 | 26.620,00€ | ERDF funds |
| Ramón y Cajal contract grants: Yuemin Ding (RYC2021) | RYC2021-002639-C | MINISTRY OF SCIENCE, INNOVATION AND UNIVERSITIES | University of Navarra | PROJECTS FOR THE GENERATION OF KNOWLEDGE | 15-12-2022 | 236.350,00€ | - |
| Influence on the expression of genetic variants (eQTL) and its potential as a biomarker in multiple sclerosis. | 2022333040 | EUSKO JAURLARITZA - BASQUE GOVERNMENT | University of Navarra | department of Health. Grants to projects of research and development in health 2022. | 15-12-2022 | 27.459,58€ | - |
| Involvement of adipo-myokines in the development of sarcopenic obesity and associated comorbidities. | PI22/00223 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES Projects research | 14-12-2022 | 123.420,00€ | ERDF funds |
| New strategies for the treatment of microcytic lung cancer based on the elimination of the immunosuppressive microenvironment due to tumor cell intrinsic factors | PI22/01253 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES Projects research | 14-12-2022 | 244.420,00€ | - |
| Characterization of vascular oxidative stress in the pathophysiology of diabetes: NADPH oxidase 5 as a potential therapeutic target. | PI22/01450 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES Projects research | 14-12-2022 | 183.920,00€ | ERDF funds |
